Navigation Links
CV Therapeutics to Host Investor Science Day on Thursday, February 7, 2008
Date:1/31/2008

PALO ALTO, Calif., Jan. 31 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX) today announced that it will host an Investor Science Day for the financial community in New York City on Thursday, February 7, 2008 beginning at 9:00 a.m. EST.

The event will be webcast live and available for replay on the company's Web site, http://www.cvt.com.

About CV Therapeutics

CV Therapeutics, Inc., headquartered in Palo Alto, California, is a biopharmaceutical company focused on applying molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases.

CV Therapeutics' approved product, Ranexa(R) (ranolazine extended-release tablets), is indicated for the treatment of chronic angina in patients who have not achieved an adequate response with other antianginal drugs, and should be used in combination with amlodipine, beta-blockers or nitrates.

CV Therapeutics' clinical and preclinical drug development candidates and programs include regadenoson, which is being developed for potential use as a pharmacologic stress agent in myocardial perfusion imaging studies, and CVT-6883, which is being developed as a potential treatment for cardiopulmonary diseases. Regadenoson and CVT-6883 have not been determined by any regulatory authorities to be safe or effective in humans for any use.

Except for the historical information contained herein, the matters set forth in this press release are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncer
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimers Treatments
2. Amsterdam Molecular Therapeutics to Appoint Philippe van Holle (Celgene) to Supervisory Board
3. CV Therapeutics to Announce 2007 Fourth Quarter and Year End Financial Results on Tuesday, February 26, 2008
4. Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc.
5. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
6. Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. Cell Therapeutics, Inc. (CTI) Shareholders Authorize Share Increase at Special Meeting of Shareholders
8. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
9. Nile Therapeutics Appoints Gregory W. Schafer to Board of Directors
10. Arno Therapeutics Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds
11. ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...wire-FirstCall/ -- eResearchTechnology, Inc.,(eRT...lized ECG and eClinical,technology, ePRO and othe...medical device and related industries, announced t...President and Chief Executive Officer, and Keith,...e scheduled to present at,the Piper Jaffray Healt...
(Date:12/2/2008)...wswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical,...nd supplier,of modernized traditional Chinese med...unced the implementation of a new sales and market...hospital clients into three classes in order,to o... The new strategy has classified distributors i...
(Date:12/2/2008)...RNewswire/ -- GeneGo, Inc., the leading systems bi...has become a certified GeneGo Center of Excellence...ccess to GeneGo,s MetaCore data analysis suite, tr...e is a world-class biomedical research facility ru...ut many departments, including research in cancer,...
(Date:12/2/2008)..., December 2 NicOx S.A.,... signed an agreement with,DSM for the commercial ...ce,(or API, active pharmaceutical ingredient). Na...and the first compound in the,Cyclooxygenase-Inhi...i-inflammatory agents, which recently achieved pos...
Breaking Biology Technology:eResearchTechnology, Inc. to Present at the Piper Jaffray Health Care Conference on December 2, 2008 2Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth 2Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth 3The Burnham Institute for Medical Research Becomes a GeneGo Center of Excellence Using MetaCore for Stem Cell Research and Neurology 2NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 2NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 3NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 4
...d flags in Midwest technology job offers and made ...ctive employer is someone who,s worth your time. ,...ing (even something small like a minor salary bump... see whether the company,s response to candidates ...,We heard from Nine2Five reader and local techno...
...Though California recently made the extraordinary ...esearch in the wake of President Bushs policy (whi...t-associated research in this area), Wisconsin is ...sconsin is also the state where the University of ...h Foundation (WARF) hold the key patents. , ,Wisco...
...ught all outstanding stock of Texas-based VectorS...ctions and check image processing. , ,Metavante, a...tober that it would buy VectorSGIs stock for $100 ... owned subsidiary. The move followed Metavantes ac... company that works on electronic check imaging. ,...
...e Sec. Cory Nettles to talk about aiding entrepren...ommerce will fund a public-sector coalition to pro...r assistance at centers around the state, Governor...will provide $1 million per year for five years, h...er contributions this year. After a competitive bi...
Other Biology Technology:One reader asked for more, and got it 2One reader asked for more, and got it 3One reader asked for more, and got it 4One reader asked for more, and got it 5Third coast of biotechnology makes strong showing at VC conference 2Third coast of biotechnology makes strong showing at VC conference 3Third coast of biotechnology makes strong showing at VC conference 4Third coast of biotechnology makes strong showing at VC conference 5State and university form network for entrepreneurial outreach 2State and university form network for entrepreneurial outreach 3
(Date:12/2/2008)... , Performing systematic reviews of nutrition rel...ountered in the field of medicine. In a new articl...describe the steps, strengths, and limitations of ...ss the factors that impact the results. , Syste...reviews, provide objective assessments with pre-sp...
(Date:12/1/2008)... , Vienna, 2 December 2008 - The International At...ed investment in a plant breeding technique that c...people out of the hunger trap. , IAEA scientists...lants that adapt to harsh climate conditions such ...ain diseases and insect pests. Called mutation ind...
(Date:12/1/2008)... , STANFORD, Calif. Scientists around the world m... for free online, that will help them to home in o...unction. , Arend Sidow, PhD, associate professor...ersity School of Medicine, recently launched the n...as the guide to determining the role different pro...
(Date:12/1/2008)... , GAINESVILLE, Fla. The University of Florida, ...o now overseeing a national records collection for...Distinguished by a long rostrum or "saw" that make...he sawfish has become a historical and cultural ic...ss, a UF ichthyologist and curator of both the Int...
Breaking Biology News(10 mins):Experts discuss applying systematic review to the field of nutrition 2Nuclear science for food security 2Powerful online tool for protein analysis provided pro bono by Stanford geneticist 2Powerful online tool for protein analysis provided pro bono by Stanford geneticist 3Endangered sawfish focus of national collection and recovery efforts 2Arbios Announces SEPET 28TM 29 Manufacturing Agreement With NxStage Medical 1430 1Arbios Announces SEPET 28TM 29 Manufacturing Agreement With NxStage Medical 1430 2Arbios Announces SEPET 28TM 29 Manufacturing Agreement With NxStage Medical 1430 3Arbios Announces SEPET 28TM 29 Manufacturing Agreement With NxStage Medical 1430 4Ground Breaking Conference Takes on Abortion 1427 1Ground Breaking Conference Takes on Abortion 1427 2Epidemic of Anesthesia Overdosing How Can You Avoid It 3F 4334 1Epidemic of Anesthesia Overdosing How Can You Avoid It 3F 4334 2Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 4333 1Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 4333 2Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 4333 3Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 4333 4
...itute (BTI) researcher at Cornell University has r... of DNA mutations in maize (corn). , The project ...ts of knocking out the function of single genes, o...mutation, or disrupted gene. The seeds will be mad... lines could one day lead to plants with tailor-ma...
...ark Pagani in the Department of Geology and Geophy...etailed history of atmospheric carbon dioxide betw...opes of carbon in a National Science Foundation st...ergy we consume, each of us makes a contribution t...xide and methane, in the Earth,s atmosphere," said...
...bodies demonstrate enhanced cell killing compared ..., Origen Therapeutics today announced the first p...man sequence monoclonal antibodies (mAbs) produced... in the chicken oviduct and deposited into egg whi...reover, antibodies produced in this manner demonst...
... polio have today been announced in Yemen, bringin...break in the country to 22. Yemen had been polio-f...enetic investigation is ongoing to determine the p...he number of cases will rise in the immediate futu...logists and paediatricians remain on the ground, t...
Other Biology News:Researcher gets NSF grant to create mutant maize lines 2Researcher gets NSF grant to create mutant maize lines 3Stem cells grown in lab mirror normal developmental steps 2First production of human monoclonal antibodies in chicken eggs published in Nature Biotechnology 2First production of human monoclonal antibodies in chicken eggs published in Nature Biotechnology 3New Vaccine To Be Used For First Time In Polio Outbreak Response 2
...esign, The Bioactive peptides are molecules of pe... behaviour or activity which can be developed at t..., chemical and agro-food applications. In this way...uperior properties for therapeutic applications. P...
... Bovine IFNγ ELISPOT (enzyme-lined immunospo...uction at the single cell level. A spot forms at t...ed (either using a dissection microscope or automa...r of cells added to the microplate. This allows th...
... Frame DNAscope is an integrated confocal laser sc...eadily integrated into your specific application. ...or we can tailor the system to your specifications...ing design has been modularized and built onto an ...
...Pix Professional 4200A can be upgraded to the Gene...matically loads, scans, analyzes, and saves result...when the batch is complete. Line-by-line autofocus...d slides. GenePix Pro gives you complete flexibili...
Biology Products: